176 results on '"Schirrmacher, Ralf"'
Search Results
2. Type II & III inhibitors of tropomyosin receptor kinase (Trk): a 2020–2022 patent update
3. PET Imaging in Dementia: Mini-Review and Canadian Perspective for Clinical Use
4. CycloSiFA - Towards the Next Generation of Silicon-Fluoride Acceptor based Positron Emission Tomography (PET) Imaging Probes
5. Design, Synthesis, and Evaluation of an 18F-Labeling Dendrimer Radiotracer for Positron Emission Tomography (PET) Imaging of Heparanase
6. Radiolabeled Microbubbles as a Theranostic Modality in Nuclear Medicine
7. Design and synthesis of monomeric ligands based on published EGFR (epidermal growth factor receptor)-specific peptides for the diagnostic application in malignant transformations
8. Towards decreased Protodeboronation in the Late-Stage Copper-Mediated Radiofluorination of the Positron Emission Tomography Tracer for Tropomyosin Receptor Kinase [18F]TRACK
9. Dosimetry of [18F]TRACK, the first PET tracer for imaging of TrkB/C receptors in humans
10. CycloSiFA: The Next Generation of Silicon‐Based Fluoride Acceptors for Positron Emission Tomography (PET)
11. CycloSiFA: The Next Generation of Silicon‐Based Fluoride Acceptors for Positron Emission Tomography (PET)
12. Good practices for the automated production of 18F-SiFA radiopharmaceuticals
13. Correction to: Next‑generation PET/CT imaging in meningioma—first clinical experiences using the novel SSTR‑targeting peptide [18F]SiTATE
14. Type I inhibitors of tropomyosin receptor kinase (Trk): a 2020–2022 patent update
15. Toward Imaging Tropomyosin Receptor Kinase (Trk) with Positron Emission Tomography
16. Next-generation PET/CT imaging in meningioma—first clinical experiences using the novel SSTR-targeting peptide [18F]SiTATE
17. List of contributors
18. Silicon-based 18F-radiopharmaceuticals
19. Towards Radiolabeled EGFR-Specific Peptides: Alternatives to GE11
20. Comparison of somatostatin receptor expression in patients with neuroendocrine tumours with and without somatostatin analogue treatment imaged with [18F]SiTATE
21. Synthesis, Radiolabeling, and In Vitro and In Vivo Characterization of Heterobivalent Peptidic Agents for Bispecific EGFR and Integrin αvβ3 Targeting
22. [ 18 F]TRACK, a PET tracer for imaging of tropomyosin receptor kinases (Trk): efficient radiosynthesis and preliminary evaluation in the TgF344‐AD rat model of Alzheimer’s disease.
23. Synthesis of a Bifunctional Cross‐Bridged Chelating Agent, Peptide Conjugation, and Comparison of 68 Ga Labeling and Complex Stability Characteristics with Established Chelators
24. Toward Optimized 89Zr-Immuno-PET: Side-by-Side Comparison of [89Zr]Zr-DFO-, [89Zr]Zr-3,4,3-(LI-1,2-HOPO)- and [89Zr]Zr-DFO*-Cetuximab for Tumor Imaging: Which Chelator Is the Most Suitable?
25. Highlight selection of radiochemistry and radiopharmacy developments by editorial board
26. Favorable SSTR subtype selectivity of SiTATE: new momentum for clinical [18F]SiTATE PET
27. Simultaneous PET/MRI: The future gold standard for characterizing motor neuron disease—A clinico-radiological and neuroscientific perspective
28. Toward in vivo proof of binding of 18F-labeled inhibitor [18F]TRACK to peripheral tropomyosin receptor kinases
29. Toward the Development of GE11-Based Radioligands for Imaging of Epidermal Growth Factor Receptor-Positive Tumors
30. Towards In Vivo Proof-of-Binding of 18F-labeled Inhibitor [18F]TRACK to Peripheral Tropomyosin Receptor Kinases
31. Radioisotope-loaded microbubbles for cancer imaging and therapy
32. The development of heparanase-targeting radiotracers for PET imaging
33. Reducing protodeboronation using a novel boronic ester in the late-stage copper-mediated radiofluorination
34. Highlight selection of radiochemistry and radiopharmacy developments by editorial board
35. Comparison of somatostatin receptor expression in patients with neuroendocrine tumours with and without somatostatin analogue treatment imaged with [18F]SiTATE
36. Side-by-Side Comparison of Five Chelators for 89Zr-Labeling of Biomolecules: Investigation of Chemical/Radiochemical Properties and Complex Stability
37. Synthesis and Preclinical Evaluation of [18F]SiFA-PSMA Inhibitors in a Prostate Cancer Model
38. Silicon Fluoride Acceptors (SiFAs) for Peptide and Protein Labeling with18F
39. Are heterobivalent GRPR- and VPAC1R-bispecific radiopeptides suitable for efficient in vivo tumor imaging of prostate carcinomas?
40. On the Viability of Tadalafil-Based 18F-Radiotracers for In Vivo Phosphodiesterase 5 (PDE5) PET Imaging
41. Recent Advances in the Clinical Translation of Silicon Fluoride Acceptor (SiFA) 18F-Radiopharmaceuticals
42. Design, Synthesis, In Vitro and In Vivo Evaluation of Heterobivalent SiFAlin-Modified Peptidic Radioligands Targeting Both Integrin αvβ3 and the MC1 Receptor—Suitable for the Specific Visualization of Melanomas?
43. PESIN Conjugates for Multimodal Imaging: Can Multimerization Compensate Charge Influences on Cell Binding Properties? A Case Study
44. Dosimetry and optimal scan time of [18F]SiTATE-PET/CT in patients with neuroendocrine tumours
45. PET Imaging of Meningioma Using the Novel SSTR-Targeting Peptide 18F-SiTATE
46. Development and biological evaluation of[18F]FMN3PA & [18F]FMN3PU for leucine-rich repeat kinase 2 (LRRK2) in vivo PET imaging
47. Automated synthesis of [18F]Ga-rhPSMA-7/ -7.3: results, quality control and experience from more than 200 routine productions
48. αvβ3-Specific Gold Nanoparticles for Fluorescence Imaging of Tumor Angiogenesis
49. Radiosynthesis of [18F]SiFAlin-TATE for clinical neuroendocrine tumor positron emission tomography
50. Lewis Acid-Facilitated Radiofluorination of MN3PU: A LRRK2 Radiotracer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.